FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Werner Rittgen

Research Profile

Physiology

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Tumor Cell Line

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Markus Hoffmann; Anna Sophie Ihloff; Tibor Görögh; Jan Bernd Weise; Asita Fazel; Matthias Krams; Werner Rittgen; Elisabeth Schwarz; Tomas Kahn
p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
Ann-Kathrin Diercks; Anna Schwab; Werner Rittgen; Andreas Kruspel; Edgar Heuss; Johannes Schenkel
Environmental influences on the production of pre-implantation embryos.
Chengwen Zhang; Till Wenger; Jürgen Mattern; Septimia Ilea; Christian R Frey; Paul Gutwein; Peter Altevogt; Wolfram Bodenmüller; Nikolaus Gassler; Philipp A Schnabel; Hendrik Dienemann; Alexander Marmé; Markus Hohenfellner; Axel Haferkamp; Jesco Pfitzenmaier; Hermann-Josef Gröne; Armin Kolb; Peter Büchler; Markus Büchler; Helmut Friess; Werner Rittgen; Lutz Edler; Klaus-Michael Debatin; Peter H Krammer; Hans Peter Rutz; Ingrid Herr
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Werner Rittgen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Markus Hoffmann; Anna Sophie Ihloff; Tibor Görögh; Jan Bernd Weise; Asita Fazel; Matthias Krams; Werner Rittgen; Elisabeth Schwarz; Tomas Kahn
p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
International journal of cancer. Journal international du cancer 2010;127(7):1595-602.
2010: Ann-Kathrin Diercks; Anna Schwab; Werner Rittgen; Andreas Kruspel; Edgar Heuss; Johannes Schenkel
Environmental influences on the production of pre-implantation embryos.
Theriogenology 2010;73(9):1238-43.
2007: Chengwen Zhang; Till Wenger; Jürgen Mattern; Septimia Ilea; Christian R Frey; Paul Gutwein; Peter Altevogt; Wolfram Bodenmüller; Nikolaus Gassler; Philipp A Schnabel; Hendrik Dienemann; Alexander Marmé; Markus Hohenfellner; Axel Haferkamp; Jesco Pfitzenmaier; Hermann-Josef Gröne; Armin Kolb; Peter Büchler; Markus Büchler; Helmut Friess; Werner Rittgen; Lutz Edler; Klaus-Michael Debatin; Peter H Krammer; Hans Peter Rutz; Ingrid Herr
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors.
Cancer biology & therapy 2007;6(2):278-87.
2007: Klaus Braun; Leonie von Brasch; Rüdiger Pipkorn; Volker Ehemann; Jürgen W Jenne; Herbert Spring; Jürgen Debus; Bernd Didinger; Werner Rittgen; Waldemar Waldeck
BioShuttle-mediated plasmid transfer.
International journal of medical sciences 2007;4(5):267-77.
2007: Selma Ugurel; Ranjit K Thirumaran; Sandra Bloethner; Andreas Gast; Antje Sucker; Jan Muller-Berghaus; Werner Rittgen; Kari Hemminki; Jürgen C Becker; Rajiv Kumar; Dirk Schadendorf
B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.
PloS one 2007;2(2):e236.
2006: Chengwen Zhang; Benjamin Beckermann; Georgios Kallifatidis; Zheng Liu; Werner Rittgen; Lutz Edler; Peter Büchler; Klaus-Michael Debatin; Markus W Büchler; Helmut Friess; Ingrid Herr
Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma.
International journal of oncology 2006;29(5):1295-301.
2006: Chengwen Zhang; Armin Kolb; Jürgen Mattern; Nikolaus Gassler; Till Wenger; Kerstin Herzer; Klaus-Michael Debatin; Markus W Büchler; Helmut Friess; Werner Rittgen; Lutz Edler; Ingrid Herr
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy.
Cancer letters 2006;242(1):104-11.
2006: Selma Ugurel; Dirk Schadendorf; Claudia Pföhler; Karsten Neuber; Adina Thoelke; Jens Ulrich; Axel Hauschild; Konstanze Spieth; Martin Kaatz; Werner Rittgen; Stefan Delorme; Wolfgang Tilgen; Uwe Reinhold
In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5454-63.
2006: Markus Hoffmann; Nina Klose; Stefan Gottschlich; Tibor Görögh; Asita Fazel; Claudia Lohrey; Werner Rittgen; Petra Ambrosch; Elisabeth Schwarz; Tomas Kahn
Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms.
Cancer letters 2006;239(1):64-70.
2006: Bram Stieltjes; Stefan Klussmann; Michael Bock; Reiner Umathum; Jain Mangalathu; Elisabeth Letellier; Werner Rittgen; Lutz Edler; Peter H Krammer; Hans-Ulrich Kauczor; Ana Martin Villalba; Marco Essig
Manganese-enhanced magnetic resonance imaging for in vivo assessment of damage and functional improvement following spinal cord injury in mice.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2006;55(5):1124-31.
2006: Dirk Schadendorf; Selma Ugurel; Beatrice Schuler-Thurner; F O Nestle; A Enk; Eva-B Bröcker; S Grabbe; Werner Rittgen; Lutz Edler; Antje Sucker; Christine Zimpfer-Rechner; T Berger; Jivko Kamarashev; G Burg; H Jonuleit; A Tüttenberg; Jürgen C Becker; Petra Keikavoussi; E Kämpgen; Gerold Schuler
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):563-70.
2006: Chengwen Zhang; Alexander Marmé; Till Wenger; Paul Gutwein; Lutz Edler; Werner Rittgen; Klaus-Michael Debatin; Peter Altevogt; Jürgen Mattern; Ingrid Herr
Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas.
International journal of oncology 2006;28(2):551-8.
2006: Markus Hoffmann; Antje Orlamünder; Jan Sucher; Stefan Gottschlich; Tibor Görögh; Asita Fazel; Petra Ambrosch; Werner Rittgen; Elisabeth Schwarz; Tomas Kahn
HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers.
Anticancer research 2006;26(1B):663-70.
2006: Chengwen Zhang; Armin Kolb; Peter Büchler; Andrew C B Cato; Jürgen Mattern; Werner Rittgen; Lutz Edler; Klaus-Michael Debatin; Markus W Büchler; Helmut Friess; Ingrid Herr
Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.
BMC cancer 2006;6():61.
2006: Chengwen Zhang; Jürgen Mattern; Axel Haferkamp; Jesco Pfitzenmaier; Markus Hohenfellner; Werner Rittgen; Lutz Edler; Klaus-Michael Debatin; E Groene; Ingrid Herr
Corticosteroid-induced chemotherapy resistance in urological cancers.
Cancer biology & therapy 2006;5(1):59-64.
2005: Selma Ugurel; Nellie Bell; Antje Sucker; Anette Zimpfer; Werner Rittgen; Dirk Schadendorf
Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma.
International journal of cancer. Journal international du cancer 2005;117(5):825-30.
2005: Michael Heuser; Marijana Kopun; Werner Rittgen; Christof Granzow
Cytotoxicity determination without photochemical artifacts.
Cancer letters 2005;223(1):57-66.
2005: Selma Ugurel; Ralf Hildenbrand; Anette Zimpfer; Paul La Rosée; Peter Paschka; Antje Sucker; Petra Keikavoussi; Jürgen C Becker; Werner Rittgen; Andreas Hochhaus; Dirk Schadendorf
Lack of clinical efficacy of imatinib in metastatic melanoma.
British journal of cancer 2005;92(8):1398-405.
2005: Markus Hoffmann; Tibor Görögh; Stefan Gottschlich; Claudia Lohrey; Werner Rittgen; Petra Ambrosch; Elisabeth Schwarz; Tomas Kahn
Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients.
Cancer letters 2005;218(2):199-206.
2003: Nikolaus Becker; Alexandra Nieters; Werner Rittgen
Single nucleotide polymorphism--disease relationships: statistical issues for the performance of association studies.
Mutation research 2003;525(1-2):11-8.
2003: Manfred Volm; Reet Koomägi; Werner Rittgen
Cellular predictive factors of drug resistance in non-small cell lung carcinomas.
Methods in molecular medicine 2003;75():39-51.
2002: U Hofmann; M Szedlak; Werner Rittgen; E G Jung; Dirk Schadendorf
Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival.
British journal of cancer 2002;87(2):151-7.
2002: Lutz Edler; I Geisler; Werner Rittgen
Symposium on mathematical, statistical, and computational methods for cancer surveillance and cancer screening. July 27, 2001 Heidelberg, Deutsches Krebsforschungszentrum.
Journal of cancer research and clinical oncology 2002;128(4):231-4.
2001: Jeannine Lacroix; H D Becker; Stefan M Woerner; Werner Rittgen; Peter Drings; Magnus von Knebel Doeberitz
Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR.
International journal of cancer. Journal international du cancer 2001;92(1):1-8.
2001: Nahid Rajaee-Behbahani; Peter Schmezer; Angela Risch; Werner Rittgen; Klaus Kayser; Hendrik Dienemann; Volker Schulz; Peter Drings; S Thiel; Helmut Bartsch
Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer.
International journal of cancer. Journal international du cancer 2001;95(2):86-91.
2001: Werner Rittgen; N Becker
Statistical issues of quality control in organised breast cancer screening.
Journal of epidemiology and biostatistics 2001;6(6):425-32.
2001: Peter Schmezer; Nahid Rajaee-Behbahani; Angela Risch; S Thiel; Werner Rittgen; Peter Drings; Hendrik Dienemann; Klaus Kayser; Volker Schulz; Helmut Bartsch
Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes.
Mutagenesis 2001;16(1):25-30.
2000: Werner Rittgen; N Becker
SMR analysis of historical follow-up studies with missing death certificates.
Biometrics 2000;56(4):1164-9.
2000: Manfred Volm; Werner Rittgen
Cellular predictive factors for the drug response of lung cancer.
Anticancer research 2000;20(5B):3449-58.
2000: D Djukanovic; U Hofmann; Antje Sucker; Werner Rittgen; Dirk Schadendorf
Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
Anticancer research 2000;20(3B):2203-7.
1998: Manfred Volm; Reet Koomägi; Werner Rittgen
Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma.
International journal of cancer. Journal international du cancer 1998;79(3):294-9.
1998: Manfred Volm; Werner Rittgen; Peter Drings
Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.
British journal of cancer 1998;77(4):663-9.
1997: Manfred Volm; Reet Koomägi; Gerd Stammler; Werner Rittgen; Felix Zintl; Axel Sauerbrey
Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia.
International journal of cancer. Journal international du cancer 1997;74(5):508-12.
1994: N Becker; Werner Rittgen
Fitting epidemiologic follow-up studies with cumulative damage models.
Mathematical biosciences 1994;120(2):147-63.
1992: N Becker; Werner Rittgen
Fitting cancer mortality data with cumulative damage models.
Mathematical biosciences 1992;108(1):57-73.